Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WAY
WAY logo

WAY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
20.005
Open
19.100
VWAP
19.66
Vol
7.40M
Mkt Cap
3.82B
Low
19.065
Amount
145.47M
EV/EBITDA(TTM)
11.95
Total Shares
191.81M
EV
4.95B
EV/OCF(TTM)
14.98
P/S(TTM)
3.09
Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.
Show More

Events Timeline

(ET)
2026-05-19
12:10:00
Waystar Stock Rises 7.0% to $19.84
select
2026-05-19
10:10:00
Waystar Stock Rises 7.7% to $19.97
select
2026-05-19
08:10:00
Waystar Authorizes Stock Repurchase Plan Up to $200M
select
2026-04-30 (ET)
2026-04-30
16:30:00
Dow Rises 790.33 Points, Nasdaq Gains 219.07 Points
select
2026-04-30
12:00:00
Major Averages Rebound, Nasdaq Up 0.19%
select

News

PRnewswire
7.5
06-09PRnewswire
Healthcare Leaders Show Strong Interest in AI-Powered Revenue Cycle Platform
  • Industry Consensus: Waystar's 'State of the Mid-Revenue Cycle' report reveals unanimous interest among healthcare finance leaders in an AI platform connecting mid-cycle to final claims, yet 86% rely on manual data transfers, highlighting significant integration challenges in the sector.
  • Efficiency Improvement Needs: The survey indicates that 82% of leaders struggle to keep pace with rapidly changing payer clinical policies, and 56% are dissatisfied with their ability to predict and prevent claim denials, underscoring the urgent need for more efficient solutions in revenue cycle management.
  • Revenue Potential: Waystar's analysis shows that a connected, AI-powered mid-cycle can generate millions in incremental revenue for hospitals, improve quality scores, and reduce denial risks, emphasizing the critical importance of data integration.
  • Strategic Recommendations: The report outlines five actionable strategies for organizations to enhance visibility, prevent revenue leakage earlier, and achieve stronger ROI, showcasing the transformative potential of AI platforms in healthcare payments.
Newsfilter
6.5
06-09Newsfilter
Waystar Releases New Report on Healthcare Revenue Cycle
  • Industry Consensus: Waystar's 'State of the Mid-Revenue Cycle' report reveals that 86% of healthcare finance leaders lack true system integration and rely on manual data transfers, indicating a strong demand for a unified AI platform that could maximize revenue potential.
  • Revenue Potential: The analysis shows that organizations fully leveraging Waystar's platform achieve an incremental reimbursement of $2.17 million per 10,000 discharges, with an 87% increase in Clinical Documentation Integrity (CDI) program impact, enhancing both financial returns and care quality.
  • Conversion Rate Improvement: Providers using Waystar's advanced utilization management workflows see a 13% increase in observation-to-inpatient conversion rates, with an 82% accuracy in predicting inpatient status within the first hour of patient visits, effectively reducing medical necessity denial rates.
  • Revenue Protection: Waystar's anomaly detection safeguards revenue before claims are generated, with early adopters unlocking up to $3 million in incremental revenue per 10,000 admissions, highlighting the critical role of real-time intelligence in revenue outcomes.
seekingalpha
6.5
06-01seekingalpha
Mid-Cap Healthcare Stocks Valuation Analysis
  • Valuation Score Overview: According to Seeking Alpha's valuation grades, Acadia Healthcare Company (ACHC) and Waystar Holding (WAY) received an A rating, indicating their attractiveness relative to peers and suggesting potential investor interest for gains.
  • Market Performance Highlights: Among mid-cap healthcare stocks with market capitalizations between $2B and $10B, BioCryst Pharmaceuticals (BCRX) stands out with a B+ valuation grade, reflecting its competitiveness and investment appeal in the biopharmaceutical sector.
  • Valuation Metrics Analysis: The valuation scores are derived from a comprehensive analysis of multiple metrics, including P/E, PEG, EV/Sales, and EV/EBITDA, providing investors with a robust basis for informed investment decisions.
  • Industry Trend Insights: As the healthcare sector continues to evolve, investor focus on mid-cap healthcare stocks is increasing, particularly those demonstrating strong valuation performance, which may attract greater investment inflows in the future.
PRnewswire
1.0
05-20PRnewswire
Waystar CEO to Speak at 46th Annual William Blair Growth Stock Conference
  • CEO Speaking Engagement: Waystar's CEO Matt Hawkins is scheduled to speak at the 46th Annual William Blair Growth Stock Conference on June 2, 2026, at 10:40 AM CT, highlighting the company's leadership in healthcare payment software.
  • Live Webcast Availability: The presentation will be available via live webcast on Waystar's Investor Relations website, ensuring global investors can access real-time updates and enhancing transparency and investor confidence.
  • Extensive Client Base: Waystar serves over 30,000 clients, representing more than 1 million distinct providers, including 16 of the institutions listed in U.S. News Best Hospitals, underscoring its significance and influence in the industry.
  • Transaction Processing Capacity: The company processes over 7.5 billion healthcare payment transactions annually, involving over $2.4 trillion in gross claims, covering approximately 60% of U.S. patients and one in three U.S. hospital discharges, demonstrating its critical role in healthcare payments.
Yahoo Finance
1.0
05-20Yahoo Finance
Waystar CEO to Speak at William Blair Conference
  • Conference Speaking Engagement: Waystar's CEO Matt Hawkins is scheduled to speak at the 46th Annual William Blair Growth Stock Conference on June 2, 2026, at 10:40 a.m. CT, highlighting the company's leadership in healthcare payment software.
  • Live Webcast Availability: The presentation will be available via live webcast on Waystar's Investor Relations website, ensuring global investors can access real-time updates and enhancing transparency and investor confidence.
  • Extensive Client Base: Waystar serves over 30,000 clients, representing more than 1 million distinct providers, including 16 of the institutions listed in U.S. News Best Hospitals, showcasing its significant influence and market share in the healthcare sector.
  • Transaction Processing Capacity: Annually, Waystar processes over 7.5 billion healthcare payment transactions, encompassing over $2.4 trillion in gross claims, covering approximately 60% of U.S. patients and one in three U.S. hospital discharges, underscoring its critical role in healthcare payments.
seekingalpha
8.0
05-19seekingalpha
Waystar Authorizes $200M Stock Repurchase Plan
  • Stock Repurchase Plan: Waystar's board has authorized a stock repurchase plan of up to $200 million aimed at enhancing shareholder value through the buyback of common stock, although the plan does not obligate the company to acquire any specific amount of shares.
  • Flexibility and Discretion: The repurchase plan allows the company to suspend or discontinue it at any time at its discretion, reflecting the company's flexibility in capital allocation and potential adjustments based on market conditions.
  • Stable Revenue Guidance: Waystar projects its 2026 revenue to be between $1.274 billion and $1.294 billion, while adjusting its Q2 sequential growth outlook to flat to a 1% decline, indicating a cautiously optimistic view on future revenues.
  • Market Reaction: While the repurchase plan may have a short-term positive impact on stock prices, the company's conservative revenue guidance could raise investor concerns about demand weakness, potentially affecting market confidence.
Wall Street analysts forecast WAY stock price to rise
17 Analyst Rating
Wall Street analysts forecast WAY stock price to rise
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
40.00
Averages
47.81
High
54.00
Current: 0.000
sliders
Low
40.00
Averages
47.81
High
54.00
JPMorgan
Overweight
maintain
$38 -> $34
AI Analysis
2026-06-25
New
Reason
JPMorgan
Price Target
$38 -> $34
AI Analysis
2026-06-25
New
maintain
Overweight
Reason
JPMorgan lowered the firm's price target on Waystar to $34 from $38 and keeps an Overweight rating on the shares. The firm adjusted targets in the health technology space heading into the second half of 2026. Rising healthcare costs remain a "durable driver" of demand, the analyst tells investors in a research note. JPMorgan moved its price targets to year-end 2027 from 2026.
Barclays
Glen Santangelo
Overweight
downgrade
$36 -> $25
2026-05-20
Reason
Barclays
Glen Santangelo
Price Target
$36 -> $25
2026-05-20
downgrade
Overweight
Reason
Barclays analyst Glen Santangelo lowered the firm's price target on Waystar to $25 from $36 and keeps an Overweight rating on the shares. The firm believes the company's leveraged buyout math "could create a floor" for the shares. Barclays does not expect a transaction in the near-term. However, with Waystar trading down on AI concerns, the firm finds the company's leveraged buyout math "increasingly compelling." The longer-term potential for a transaction "may start to provide a floor for the stock," the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WAY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Waystar Holding Corp (WAY.O) is 11.34, compared to its 5-year average forward P/E of 30.89. For a more detailed relative valuation and DCF analysis to assess Waystar Holding Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
30.89
Current PE
11.34
Overvalued PE
42.44
Undervalued PE
19.34

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.78
Current EV/EBITDA
9.93
Overvalued EV/EBITDA
18.97
Undervalued EV/EBITDA
12.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.08
Current PS
2.56
Overvalued PS
6.42
Undervalued PS
3.73

Financials

AI Analysis
Annual
Quarterly

Whales Holding WAY

B
Burkehill Global Management, LP
Holding
WAY
+71.00%
3M Return
O
Oberweis Asset Management, Inc.
Holding
WAY
+53.93%
3M Return
J
Jaunty Global Limited
Holding
WAY
+31.16%
3M Return
P
PointState Capital LP
Holding
WAY
+22.01%
3M Return
A
ArrowMark Colorado Holdings, LLC
Holding
WAY
+13.21%
3M Return
G
Ghisallo Capital Management LLC
Holding
WAY
+9.37%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Waystar Holding Corp (WAY) stock price today?

The current price of WAY is 19.9 USD — it has increased 4.96

What is Waystar Holding Corp (WAY)'s business?

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.

What is the price predicton of WAY Stock?

Wall Street analysts forecast WAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WAY is47.81 USD with a low forecast of 40.00 USD and a high forecast of 54.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Waystar Holding Corp (WAY)'s revenue for the last quarter?

Waystar Holding Corp revenue for the last quarter amounts to 313.87M USD, increased 22.40

What is Waystar Holding Corp (WAY)'s earnings per share (EPS) for the last quarter?

Waystar Holding Corp. EPS for the last quarter amounts to 0.22 USD, increased 37.50

How many employees does Waystar Holding Corp (WAY). have?

Waystar Holding Corp (WAY) has 1700 emplpoyees as of June 27 2026.

What is Waystar Holding Corp (WAY) market cap?

Today WAY has the market capitalization of 3.82B USD.